Omega Therapeutics Inc
NASDAQ:OMGA

Watchlist Manager
Omega Therapeutics Inc Logo
Omega Therapeutics Inc
NASDAQ:OMGA
Watchlist
Price: 0.0485 USD 7.78% Market Closed
Market Cap: 2.7m USD

Omega Therapeutics Inc
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Omega Therapeutics Inc
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Omega Therapeutics Inc
NASDAQ:OMGA
EPS (Diluted)
-$1
CAGR 3-Years
-42%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
EPS (Diluted)
$1
CAGR 3-Years
-44%
CAGR 5-Years
-20%
CAGR 10-Years
-2%
Gilead Sciences Inc
NASDAQ:GILD
EPS (Diluted)
$6
CAGR 3-Years
35%
CAGR 5-Years
45%
CAGR 10-Years
-5%
Amgen Inc
NASDAQ:AMGN
EPS (Diluted)
$12
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
EPS (Diluted)
$14
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
EPS (Diluted)
$42
CAGR 3-Years
-4%
CAGR 5-Years
9%
CAGR 10-Years
24%
No Stocks Found

Omega Therapeutics Inc
Glance View

Market Cap
2.7m USD
Industry
Biotechnology

Omega Therapeutics, Inc. engages in the development of DNA-sequence-targeting, mRNA-encoded therapeutics. The company is headquartered in Cambridge, Massachusetts. The company went IPO on 2021-07-30. The firm is engaged in a systematic approach to use mRNA therapeutics as programmable epigenetic medicines by leveraging its OMEGA Epigenomic Programming platform. Its OMEGA Epigenomic Programming platform harnesses the power of epigenetics, the mechanism that controls gene expression and every aspect of an organism's life from cell genesis, growth, and differentiation to cell death. The company has deciphered the three-dimensional architecture of the human genome and its accompanying regulators, which are organized into distinct and evolutionarily conserved structures called Insulated Genomic Domains (IGDs). The OMEGA platform enables to systematically identify and validate thousands of DNA-sequence-based epigenomic zip codes within IGDs. Its pipeline consists of early-stage, preclinical programs that span regenerative medicine, multigenic diseases including immunology, oncology, and select monogenic diseases.

OMGA Intrinsic Value
Not Available

See Also

What is Omega Therapeutics Inc's EPS (Diluted)?
EPS (Diluted)
-1.8 USD

Based on the financial report for Dec 31, 2023, Omega Therapeutics Inc's EPS (Diluted) amounts to -1.8 USD.

What is Omega Therapeutics Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 3Y
-42%

Over the last year, the EPS (Diluted) growth was 16%. The average annual EPS (Diluted) growth rates for Omega Therapeutics Inc have been -42% over the past three years .

Back to Top